The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Dr. Amy Heimberger on Better Imaging and Combination Therapies in Glioblastoma

Amy Heimberger, MD
Published Online:11:13 PM, Fri January 29, 2016

Amy Heimberger, MD, professor in the Department of Neurosurgery, University of Texas MD Anderson Cancer Center, discusses the future of treatment for glioblastoma multiforme (GBM). Heimberger says the treatment paradigm's future is two-pronged, in that it will consist of both combination therapies that activate the immune system and prevent immunosuppression, as well as understand CT and MRI scans of brain cancer patients.

Heimberger says as it currently stands, CT and MRI scans do not clearly show if a patient's tumor is back or if the unidentified mass on the scan is an immune response. She adds that inflammatory imaging will be the future of these scans, so medical professionals can make that distinction and ease patients' worries.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.